B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.

Authors :: Fürstenau M
Fink AM
Schilhabel A
Weiss J
Robrecht S
Eckert R
de la Serna J
Crespo M
Coscia M
Vitale C
Böttcher S
Weppner G
Ritgen M
Stilgenbauer S
Tausch E
Fischer K
Hallek M
Eichhorst B
Brüggemann M
Herling CD
Source :: Blood [Blood] 2021 Apr 22; Vol. 137 (16), pp. 2267-2271.
Publication Year :: 2021

Subjects :: B-Lymphocytes drug effects
B-Lymphocytes pathology
Female
Humans
Immunologic Factors adverse effects
Incidence
Lenalidomide adverse effects
Leukemia, Lymphocytic, Chronic, B-Cell pathology
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology
Risk Factors
Immunologic Factors therapeutic use
Lenalidomide therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell complications
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma etiology

Full Text Access

Tools